FC
Finepoint Capital Portfolio holdings
AUM
$504M
This Quarter Return
+0.45%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$867M
AUM Growth
+$867M
(+5.4%)
Cap. Flow
+$56.6M
Cap. Flow
% of AUM
6.53%
Top 10 Holdings %
Top 10 Hldgs %
90.1%
Holding
31
New
5
Increased
10
Reduced
4
Closed
5
Top Buys
| 1 |
Liberty Live Group Series C
LLYVK
|
$55.3M |
| 2 |
Xencor
XNCR
|
$15.2M |
| 3 |
Avidity Biosciences
RNA
|
$11.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$3.54M |
| 5 |
Sarepta Therapeutics
SRPT
|
$3.45M |
Top Sells
| 1 |
Travere Therapeutics
TVTX
|
$24.9M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$13.9M |
| 3 |
QXO
QXO Inc
QXO
|
$13M |
| 4 |
Revolution Medicines
RVMD
|
$949K |
| 5 |
argenx
ARGX
|
$923K |
Sector Composition
| 1 | Industrials | 45.73% |
| 2 | Healthcare | 30.46% |
| 3 | Communication Services | 23.76% |
| 4 | Energy | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDI.WS
26
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
| – | – |
-655,200
| Closed | -$8.58K |
|
|
27
Acadia Pharmaceuticals
ACAD
$4.4B
| – | – |
-905,384
| Closed | -$13.9M |
|
28
iShares Russell 2000 ETF
IWM
$66.9B
| – | – |
0
| – | – |
|
29
SPDR S&P 500 ETF Trust
SPY
$655B
| – | – |
0
| – | – |
|
|
30
Travere Therapeutics
TVTX
$1.69B
| – | – |
-1,782,267
| Closed | -$24.9M |
|
|
IVCPW
31
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
| – | – |
-490,000
| Closed | -$39.2K |
|